Browse studies
Find your next paid study
3 recruiting studies matching your filters
Adrenoleukodystrophy National Registry Study
The aim of this registry to understand the natural history and disease progression in ALD and potentially develop bio-markers using the biospecimens collected …
ALD (Adrenoleukodystrophy)AdrenoleukodystrophyCerebral Adrenoleukodystrophy
Estimated
~$10 – $750
Masonic Cancer Center, University of MinnesotaNCT03789721
Phase 3
A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adrenoleukodystrophy
A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adults Male Subjects with Cerebral Adrenoleukodystrophy.
Cerebral Adrenoleukodystrophy (cALD)
Estimated
~$10 – $8,750
Minoryx Therapeutics, S.L.NCT05819866
A Postmarketing, Prospective, Multicenter, Observational, Long-Term Safety and Effectiveness Registry Study of Patients With Cerebral Adrenoleukodystrophy (CALD) Treated With Elivaldogene Autotemcel (Stargazer)
The main aim of this study is to assess and describe the safety outcomes, including newly diagnosed malignancies, of patients with CALD treated with eli-cel in…
Cerebral Adrenoleukodystrophy (CALD)
Estimated
~$10 – $1,050
Genetix Biotherapeutics Inc.NCT06224413